One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

Published Date: 13 Dec 2024

Higher response rate, PFS, OS with cilta-cel, but ide-cel had lower rate of severe toxicity

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

2.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

3.

Base-edited T-cell therapy offers additional hope for treating resistant leukemia.

4.

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

5.

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot